can anyone use glp 1 Navigating GLP-1 in therapy GLP-1 Updates for Employers: Demand,

Description

Retatrutide is an investigational triple hormone agonist (GLP-1, GIP, glucagon) showing promising early results for obesity and type 2 diabetes, while tirzepatide is an FDA-approved dual agonist (GLP-1, GIP) available for use today

Others continue for 612 months , with regular reviews to adjust or taper as their progress continues

It is important to note that most available data reflect relatively short to medium-term exposure (typically under five years)

Dry mouth and taste changes Saliva is essential for taste perception

The case settled in March 2026: Novo dropped the lawsuit in exchange for Hims agreeing to transition its platform entirely to authorized, branded semaglutide products and to cease all advertising of compounded GLP-1 alternatives